Assignee
ASHER BIOTHERAPEUTICS INC
US·3 granted patents·8 pending applications·3 citations·filing 2020–2025
Top patents by PatentIndex Score
11 records- 0187US12122827B2IL-21 polypeptides and targeted constructsASHER BIOTHERAPEUTICS INC·Filed 2023·Granted Oct 22, 2024·1 cites·30 claims
- 0285US12024559B2Fusions with CD8 antigen binding molecules for modulating immune cell functionASHER BIOTHERAPEUTICS INC·Filed 2021·Granted Jul 2, 2024·2 cites·95 claims
- 0379US2025034242A1Il-21 polypeptides and targeted constructsASHER BIOTHERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0475US12247072B2IL-21 polypeptides and targeted constructsASHER BIOTHERAPEUTICS INC·Filed 2023·Granted Mar 11, 2025·0 cites·30 claims
- 0569US2025197489A1Il-21 polypeptides and targeted constructsASHER BIOTHERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0666US2024417470A1Fusions with cd8 antigen binding molecules for modulating immune cell functionASHER BIOTHERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0761US2026098090A1Fusions with cd8 antigen binding molecules for treating chronic viral infectionASHER BIOTHERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0857US2025339519A1Combination of cytokine fusion proteins with cd8 antigen binding moleculesASHER BIOTHERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0952US2024043490A1Targeted cytokine construct for engineered cell therapyASHER BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1048US2024010695A1Fusions of mutant interleukin-10 polypeptides with antigen binding molecules for modulating immune cell functionASHER BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1147US2022251202A1Fusions of mutant interleukin-2 polypeptides with antigen binding molecules for modulating immune cell functionASHER BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →